| Application number | Title of the application | Filing Date | Status |
|---|
| 18/083665 | ANTIBODIES TO THE C3D FRAGEMENT OF COMPLEMENT COMPONENT 3 | Dec 18, 2022 | Abandoned |
Array
(
[id] => 20384752
[patent_doc_number] => RE050682
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2025-12-02
[patent_title] => Immunoglobulin variable domains
[patent_app_type] => reissue
[patent_app_number] => 18/062103
[patent_app_country] => US
[patent_app_date] => 2022-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 112
[patent_figures_cnt] => 43
[patent_no_of_words] => 69763
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18062103
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/062103 | Immunoglobulin variable domains | Dec 5, 2022 | Issued |
Array
(
[id] => 20156250
[patent_doc_number] => RE050528
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2025-08-12
[patent_title] => Compounds and compositions for modulating EGFR mutant kinase activities
[patent_app_type] => reissue
[patent_app_number] => 18/057062
[patent_app_country] => US
[patent_app_date] => 2022-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19599
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 496
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18057062
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/057062 | Compounds and compositions for modulating EGFR mutant kinase activities | Nov 17, 2022 | Issued |
Array
(
[id] => 20436780
[patent_doc_number] => RE050715
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2025-12-30
[patent_title] => Synthetic biochemistry molecular purge valve module that maintain co-factor balance
[patent_app_type] => reissue
[patent_app_number] => 18/052136
[patent_app_country] => US
[patent_app_date] => 2022-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 8555
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18052136
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/052136 | Synthetic biochemistry molecular purge valve module that maintain co-factor balance | Nov 1, 2022 | Issued |
Array
(
[id] => 20270073
[patent_doc_number] => RE050636
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2025-10-14
[patent_title] => Accurate molecular barcoding
[patent_app_type] => reissue
[patent_app_number] => 18/050449
[patent_app_country] => US
[patent_app_date] => 2022-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 23
[patent_no_of_words] => 19271
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18050449
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/050449 | Accurate molecular barcoding | Oct 26, 2022 | Issued |
Array
(
[id] => 19614967
[patent_doc_number] => 20240400647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => Biologically Active Collagen Hybridizing Peptides
[patent_app_type] => utility
[patent_app_number] => 18/698649
[patent_app_country] => US
[patent_app_date] => 2022-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -52
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18698649
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/698649 | Biologically Active Collagen Hybridizing Peptides | Oct 6, 2022 | Pending |
| 17/819591 | PREPARATION AND COMPOSITION OF INTER-ALPHA INHIBITOR PROTEINS FROM HUMAN PLASMA FOR THERAPEUTIC USE | Aug 11, 2022 | Pending |
Array
(
[id] => 20518705
[patent_doc_number] => 20260042809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-02-12
[patent_title] => PROCESS FOR THE PREPARATION OF SEMAGLUTIDE
[patent_app_type] => utility
[patent_app_number] => 18/294556
[patent_app_country] => US
[patent_app_date] => 2022-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9773
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18294556
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/294556 | PROCESS FOR THE PREPARATION OF SEMAGLUTIDE | Aug 3, 2022 | Pending |
| 17/816448 | Use of an All-D-Pentapeptide Chemokine Antagonist to Reduce Opioid Dose in a Person with Pain | Jul 31, 2022 | Abandoned |
| 90/015080 | SYSTEM, ARRAY AND NON-POROUS SOLID SUPPORT COMPRISING FIXED OR IMMOBILIZED NUCLEIC ACIDS | Jul 25, 2022 | Pending |
| 17/869925 | USE OF AN ALL-D-PENTAPEPTIDE CHEMOKINE ANTAGONIST TO REDUCE OPIOID DOSE IN A PERSON WITH PAIN | Jul 20, 2022 | Pending |
Array
(
[id] => 19496481
[patent_doc_number] => 20240335499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-10
[patent_title] => PEPTIDE HAVING ANTIDIABETIC ACTIVITY AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/574406
[patent_app_country] => US
[patent_app_date] => 2022-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5263
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18574406
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/574406 | PEPTIDE HAVING ANTIDIABETIC ACTIVITY AND USE THEREOF | Jun 27, 2022 | Pending |
Array
(
[id] => 20670943
[patent_doc_number] => 12611438
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-28
[patent_title] => Antiviral composition comprising a nucleolin-binding peptide
[patent_app_type] => utility
[patent_app_number] => 18/549549
[patent_app_country] => US
[patent_app_date] => 2022-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 15267
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18549549
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/549549 | Antiviral composition comprising a nucleolin-binding peptide | May 17, 2022 | Issued |
| 17/739055 | ANTI-BCMA ANTIBODIES AND USES THEREOF | May 5, 2022 | Pending |
Array
(
[id] => 20262209
[patent_doc_number] => RE050621
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2025-10-07
[patent_title] => Detecting breast cancer
[patent_app_type] => reissue
[patent_app_number] => 17/735477
[patent_app_country] => US
[patent_app_date] => 2022-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42095
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17735477
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/735477 | Detecting breast cancer | May 2, 2022 | Issued |
Array
(
[id] => 18869883
[patent_doc_number] => 11857663
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Stable silk protein fragment compositions
[patent_app_type] => utility
[patent_app_number] => 17/716730
[patent_app_country] => US
[patent_app_date] => 2022-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 105
[patent_figures_cnt] => 248
[patent_no_of_words] => 38010
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17716730
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/716730 | Stable silk protein fragment compositions | Apr 7, 2022 | Issued |
Array
(
[id] => 17748020
[patent_doc_number] => 20220226223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => Stable Silk Protein Fragment Compositions
[patent_app_type] => utility
[patent_app_number] => 17/716743
[patent_app_country] => US
[patent_app_date] => 2022-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17716743
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/716743 | Stable silk protein fragment compositions | Apr 7, 2022 | Issued |
Array
(
[id] => 19417382
[patent_doc_number] => 20240293505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => REVERSAL OF CTL EXHAUSTION WITH ANNEXIN V
[patent_app_type] => utility
[patent_app_number] => 18/282152
[patent_app_country] => US
[patent_app_date] => 2022-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10791
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18282152
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/282152 | REVERSAL OF CTL EXHAUSTION WITH ANNEXIN V | Mar 28, 2022 | Pending |
Array
(
[id] => 18700089
[patent_doc_number] => 11786575
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => Endoparasitic depsipeptides
[patent_app_type] => utility
[patent_app_number] => 17/696955
[patent_app_country] => US
[patent_app_date] => 2022-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53027
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17696955
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/696955 | Endoparasitic depsipeptides | Mar 16, 2022 | Issued |
Array
(
[id] => 18140799
[patent_doc_number] => 20230014640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => CARBETOCIN DRUG PRODUCT AND PROCESS FOR PREPARING SAME
[patent_app_type] => utility
[patent_app_number] => 17/684742
[patent_app_country] => US
[patent_app_date] => 2022-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19547
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17684742
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/684742 | Agitation process for preparing a carbetocin drug product | Mar 1, 2022 | Issued |